Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: Functional interactions with casein kinase Iα, Gαi proteins, and ERK1/2 signaling

Neuropharmacology

Volumn 55, Issue 5, 2008, Pages 886-899

  García Fuster, M Julia ^a   Ramos Miguel, Alfredo ^a   Miralles, Antonio ^a   García Sevilla, Jesús A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Casein kinase I ; FADD phosphorylation; Opioid agonists and antagonists; Pertussis toxin; Rat brain; SL327 (MEK inhibitor)

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; CASEIN KINASE IALPHA; DELTA OPIATE RECEPTOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FENTANYL; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHINE; MU OPIATE RECEPTOR; OPIATE AGONIST; PERTUSSIS TOXIN; SUFENTANIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; MOUSE; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; APOPTOSIS; BRAIN; CASEIN KINASE IALPHA; ENZYME INHIBITORS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR WEIGHT; NALOXONE; NARCOTIC ANTAGONISTS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 51049121781     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.06.071     Document Type: Article

References (73)

1. Abdolzade-Bavil A., Hayes S., Goretzki L., Kröger M., Anders J., and Hendriks R. Convenient and versatile subcellular extraction procedure, that facilitates classical protein expression profiling and functional protein analysis. Proteomics 4 (2004) 1397-1405
2. Alappat E., Feig C., Boyerinas B., Volkland J., Samuels M., Murmann A.E., Thorburn A., Kidd V.J., Slaughter C.A., Osborn S.L., Winoto A., Tang W.J., and Peter M.E. Phosphorylation of FADD at serine 194 by CKIα regulates its nonapoptotic activities. Molecular Cell 19 (2005) 321-332
3. Algeciras-Schimnich A., Shen L., Barnhart B.C., Murmann A.E., Burkhardt J.K., and Peter M.E. Molecular ordering of the initial signaling events of CD95. Molecular Cell Biology 22 (2002) 207-220
4. Ammon S., Mayer P., Riechert U., Tischmeyer H., and Höllt V. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Molecular Brain Research 112 (2003) 113-125
5. Audet N., Paquin-Gobeil M., Landry-Paquet O., Schiller P.W., and Piñeyro G. Internalization and Src activity regulate the time course of ERK activation by delta opioid receptor ligands. Journal of Biological Chemistry 280 (2005) 7808-7816
6. Barry U., and Zuo Z. Opioids: Old drugs for potential new applications. Current Pharmaceutical Design 11 (2005) 1343-1350
7. Bhojani M.S., Chen G., Ross B., Beer D.G., and Rehemtulla A. Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer. Cell Cycle 4 (2005) 1478-1481
8. Boronat M.A., García-Fuster M.J., and García-Sevilla J.A. Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. British Journal of Pharmacology 134 (2001) 1263-1270
9. Brandt M.R., Furness M.S., Rice K.C., Fischer B.D., and Negus S. Studies of tolerance and dependence with the δ-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation. Journal of Pharmacology and Experimental Therapeutics 299 (2001) 629-637
10. Carrington P.E., Sandu C., Wei Y., Hill J.M., Morisawa G., Huang T., Gavathiotis E., Wei Y., and Werner M.H. The structure of FADD and its mode of interaction with procaspase-8. Molecular Cell 22 (2006) 599-610
11. Chinnaiyan A.M., O'Rourke K., Tewari M., and Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81 (1995) 505-512
12. Clark M.J., and Traynor J.R. Mediation of adenylyl cyclase sensitization by PTX-insensitive GalphaoA, Galphai1 or Galphai3. Journal of Neurochemistry 99 (2006) 1494-1504
13. Desbarats J., Birge R.B., Minouni-Rongy M., Weistein D.E., Palerme J.S., and Newell M.K. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nature Cell Biology 5 (2003) 118-125
14. Di Paolo G., Lutjens R., Osen-Sand A., Sobel A., Catsicas S., and Grenningloh G. Differential distribution of stathmin and SCG10 in developing neurons in culture. Journal of Neuroscience Research 50 (1997) 1000-1009
15. Feig C., Tchikov V., Schütze S., and Peter M.E. Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling. EMBO Journal 26 (2007) 221-231
16. Fields T.A., and Casey P.J. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochemical Journal 321 (1997) 561-571
17. García-Fuster M.J., Ferrer-Alcón M., Miralles A., and García-Sevilla J.A. Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology 368 (2003) 421-431
18. García-Fuster M.J., Ferrer-Alcón M., Miralles A., and García-Sevilla J.A. Deglycosylation of Fas receptor and chronic morphine treatment up-regulate high molecular mass Fas aggregates in the rat brain. European Journal of Pharmacology 496 (2004) 63-69
19. García-Fuster M.J., Miralles A., and García-Sevilla J.A. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: Regulation by the ERK1/2 MAP kinase pathway. Neuropsychopharmacology 32 (2007) 399-411
20. García-Fuster M.J., Ferrer-Alcón M., Martín M., Kieffer B.L., Maldonado R., and García-Sevilla J.A. Effects of constitutive deletion of opioid receptors on the basal densities of Fas and Fas-associated protein with death domain (FADD) in the mouse brain: A δ-opioid tone inhibits FADD. European Neuropsychopharmacology 17 (2007) 366-374
21. García-Sevilla J.A., Ahtee L., Magnusson T., and Carlsson A. Opiate-receptor mediated changes in monoamine synthesis in rat brain. Journal of Pharmacy and Pharmacology 30 (1978) 613-621
22. Garnett T.O., Filippova M., and Duerksen-Hughes P.J. Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis. Cell Death and Differentiation 13 (2006) 1915-1926
23. Gilman C.P., and Mattson M.P. Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility?. Neuromolecular Medicine 2 (2002) 197-214
24. Gómez-Angelats M., and Cidlowski J.A. Molecular evidence for the nuclear localization of FADD. Cell Death and Differentiation 10 (2003) 791-797
25. Harlow E., and Lane D. Using Antibodies: A Laboratory Manual (1999), Cold Spring Harbor Laboratory Press, New York
26. Holmström T.H., Tran S.E.F., Johnson V.L., Ahn N.G., Chow S.C., and Eriksson J.E. Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis. Molecular Cell Biology 19 (1999) 5991-6002
27. Holmström T.H., Schmitz I., Söderström T.S., Poukkula M., Johnson V.L., Chow S.C., Krammer P.H., and Eriksson J.E. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO Journal 19 (2000) 5418-5428
28. Hua Z.C., Sohn S.J., Kang C., Cado D., and Winoto A. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity 18 (2003) 513-521
29. Izeradjene K., Douglas L., Delaney A.B., and Houghton J.A. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of Fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Cancer Research 64 (2004) 8036-8044
30. Knippschild U., Gocht A., Wolff S., Huber N., Löhler J., and Stöter M. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell Signalling 17 (2005) 675-689
31. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., and Peter M.E. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO Journal 14 (1995) 5579-5588
32. Lambert C., Landau A.M., and Desbarats J. Fas beyond death: A regenerative role for Fas in the nervous system. Apoptosis 8 (2003) 551-562
33. Law P.Y., Wong Y.H., and Loh H.H. Molecular mechanisms and regulation of opioid receptor signaling. Annual Review of Pharmacology and Toxicology 40 (2000) 389-430
34. Lee K.-H., Feig C., Tchikov V., Schickel R., Hallas C., Schütze S., Peter M.E., and Chan A.C. The role of receptor internalization in CD95 signaling. EMBO Journal 25 (2006) 1009-1023
35. Liao D., Lin H., Law P.Y., and Loh H.H. Mu-opioid receptors modulate the stability of dendritic spines. Proceedings of the National Academy of Sciences USA 102 (2005) 1725-1730
36. Ma M.C., Qian H., Ghassemi F., Zhao P., and Xia Y. Oxygen-sensitive delta-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. Journal of Biological Chemistry 280 (2005) 16208-16218
37. Mao J., Sung B., Ji R.-R., and Lim G. Neuronal apoptosis associated with morphine tolerance: Evidence for an opioid-induced neurotoxic mechanism. Journal of Neuroscience 22 (2002) 7650-7661
38. Marie-Claire C., Courtin C., Roques B.P., and Noble F. Cytoskeletal genes regulation by chronic morphine treatment in rat striatum. Neuropsychopharmacology 29 (2004) 2208-2215
39. Matsumoto N., Imamura R., and Suda T. Caspase-8 and JNK-dependent AP-1 activation is required for Fas ligand-induced IL-8 production. FEBS Journal 274 (2007) 2376-2384
40. Milanés M.V., and Laorden M.L. Effects of U-50,488H withdrawal on catecholaminergic neurones of the rat ventricle. British Journal of Pharmacology 124 (1998) 1060-1064
41. 2B receptors and MAO-A in rat tissues: Norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain. European Journal of Pharmacology 518 (2005) 234-242
42. Muppidi J.R., Lobito A.A., Ramaswamy M., Yang J.K., Wang L., Wu H., and Siegel R.M. Homotypic FADD interactions through a conserved RXDLL motif are required for death receptor-induced apoptosis. Cell Death and Differentiation 13 (2006) 1641-1650
43. Murga C., Ruíz-Gómez A., García-Higuera I., Kim C.M., Benovic J.L., and Mayor Jr. F. High affinity binding of β-adrenergic receptor kinase to microsomal membranes. Journal of Biological Chemistry 271 (1996) 985-994
44. Narita M., Kuzumaki N., Miyatake M., Sato F., Wachi H., Seyama Y., and Suzuki T. Role of δ-opioid receptor function in neurogenesis and neuroprotection. Journal of Neurochemistry 97 (2006) 1494-1505
45. O'Reilly L.A., Divisekera U., Newton K., Scalzo K., Kataoka T., Puthalakath H., Ito M., Huang D.C.S., and Strasser A. Modifications and intracellular trafficking of FADD/MORT1 and caspase-8 after stimulation of T lymphocytes. Cell Death and Differentiation 11 (2004) 724-736
46. Osborn S.L., Sohn S.J., and Winoto A. Constitutive phosphorylation mutation in Fas-associated death domain (FADD) results in early cell cycle defects. Journal of Biological Chemistry 282 (2007) 22786-22792
47. Park S.-M., Schickel R., and Peter M.E. Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Current Opinion in Cell Biology 17 (2005) 610-616
48. Pérez-San Emeterio E., Tramullas M., and Hurlé M.A. Modulation of apoptosis in the mouse brain after morphine treatments and morphine withdrawal. Journal of Neuroscience Research 83 (2006) 1352-1361
49. Peter M.E., Budd R.C., Desbarats J., Hedrick S.M., Hueber A.-O., Newell M.K., Owen L.B., Pope R.M., Tschopp J., Wajant H., Wallach D., Wiltrout N., Zörnig M., and Lynch D.H. The CD95 receptor: Apoptosis revisited. Cell 129 (2007) 447-450
50. Ramos-Miguel A., Miralles A., and García-Sevilla J.A. Morphine-induced locomotor sensitization increases FADD phosphorylation in rat brain. European Neuropsychopharmacology 17 Suppl. 4 (2007) S251-S252
51. Sandu C., Morisawa G., Wegorzewska I., Huang T., Arechiga A.F., Hill J.M., Kim T., Walsh C.M., and Werner M.H. FADD self-association is required for stable interaction with an activated death receptor. Cell Death and Differentiation 13 (2006) 2052-2061
52. Sastry P.S., and Rao K.S. Apoptosis and the nervous system. Journal of Neurochemistry 74 (2000) 1-20
53. Scaffidi C., Volkland J., Blomberg I., Hoffmann I., Krammer P.H., and Peter M.E. Phosphorylation of FADD/MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase. Journal of Immunology 164 (2000) 1236-1242
54. Scherle P.A., Ma W., Lim H., Dey S., and Traskos J.M. Regulation of cyclooxygenase-2 induction in the mouse uterus during decidualization. Journal of Biological Chemistry 275 (2000) 37086-37092
55. Screaton R.A., Kiessling S., Sanson O.J., Millar C.B., Maddison K., Bird A., Clarke A.R., and Frisch S.M. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: A potential link between genome surveillance and apoptosis. Proceedings of the National Academy of Sciences USA 100 (2003) 5211-5216
56. Sharma K., Wang R.X., Zhang L.Y., Yin D.L., Luo X.Y., Solomon J.C., Jiang R.F., Markos K., Davidson W., Scott D.W., and Shi Y.F. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacology and Therapeutics 88 (2000) 333-347
57. Shimada K., Matsuyoshi S., Nakamura M., Ishida E., Kishi M., and Konishi N. Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis. Carcinogenesis 25 (2004) 1089-1097
58. Shimada K., Matsuyoshi S., Nakamura M., Ishida E., and Konishi N. Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progression. Journal of Pathology 206 (2005) 423-432
59. Shinohara H., Udagawa J., Morishita R., Ueda H., Otani H., Semba R., Kato K., and Asano T. Gi2 signaling enhances proliferation of neural progenitor cells in the developing brain. Journal of Biological Chemistry 279 (2004) 41141-41148
60. Siegel R.M., Ka-Ming Chang F., Chun H.J., and Lenardo M.J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nature Immunology 1 (2000) 469-474
61. Takagi Y., Kikuta K.-I., Nozaki K., Fujimoto M., Hayashi J., and Hashimoto N. Neuronal expression of Fas-associated death domain protein and caspase-8 in the peridinal parenchyma of cerebral arteriovenous malformations. Journal of Neurosurgery 106 (2007) 275-282
62. Tegeder I., and Geisslinger G. Opioids as modulators of cell death and survival - Unraveling mechanisms and revealing new indications. Pharmacological Reviews 56 (2004) 351-369
63. Tourneur L., Buzyn A., and Chiocchia G. FADD adaptor in cancer. Medical Immunology 4 (2005) 1 10.1186/1476-9433-4-1
64. 5] enkephalin blocks Bax-related apoptotic processes. European Journal of Pharmacology 428 (2001) 149-151
65. Valjent E., Corvol J.-C., Trzaskos J.M., Girault J.-A., and Hervé D. Role of the ERK pathway in psychostimulant-induced locomotor sensitization. BMC Neuroscience 7 (2006) 20 10.1186/1471-2202-7-20
66. Wang G., Silva J., Krishnamurthy K., and Bieberich E. A novel isoform of prostate apoptosis response 4 (PAR-4) that co-distributes with F-actin and prevents apoptosis in neural stem cells. Apoptosis 11 (2006) 315-325
67. Werner M.H., Wu C., and Walsh C.M. Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation. Cell Cycle 5 (2006) 2332-2338
68. Yin D.-L., Ren X.-H., Zheng Z.-L., Pu L., Jiang L.-Z., Ma L., and Pei G. Etorphine inhibits cell growth and induces apoptosis in SK-N-SH cells: involvement of pertussis toxin-sensitive G proteins. Neuroscience Research 29 (1997) 121-127
69. Yoo N.J., Lee S.H., Jeong E.G., Lee J.W., Soung Y.H., Nam S.W., Kim S.H., Lee J.Y., and Lee S.H. Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers. Pathology Research and Practice 203 (2007) 73-78
70. Zhang J., Gross S.D., Schroeder M.D., and Anderson R.A. Casein kinaseIα and αL: Alternative splicing-generated kinases exhibit different catalytic properties. Biochemistry 35 (1996) 16319-16327
71. Zhang J., Gibney G.T., Zhao P., and Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. American Journal of Physiology. Cell Physiology 282 (2002) C1225-C1234
72. Zhang J., Zhang D., and Hua Z. FADD and its phosphorylation. IUBMB Life 56 (2004) 395-401
73. Zuliani C., Kleber S., Klussmann S., Wenger T., Kenzelmann M., Schreglmann N., Martínez A., del Río J.A., Soriano E., Vodrazka P., Kuner R., Groene H.J., Herr I., Krammer P.H., and Marín-Villalba A. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death and Differentiation 13 (2006) 31-40